Ali Hajigholami
1* 
, Hourieh Ansari
2 , Sakineh Ansari
1 , Shakiba Hassanzadeh
3 1 Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Community and Preventive Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Nickan Research Institute, Isfahan, Iran
Abstract
Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed. She presented to the emergency department with abnormal bleeding and spontaneous hemoptysis about ten days after a removal surgery of her epiglottis tumor. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.
Implication for health policy/practice/research/medical education:
Acquired hemophilia is a potentially life-threatening hemorrhagic disorder. There have been various reports of COVID-19- associated acquired hemophilia. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.
Please cite this paper as: Hajigholami A, Ansari H, Ansari S, Hassanzadeh S. Acquired hemophilia in a patient with SARSCoV-2 infection; a case report. J Nephropharmacol. 2022;11(2):e10453. DOI: 10.34172/npj.2022.10453.